Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

GN Store Nord

Ylin-
Alin-
Vaihto-
2026 Q1 -tulosraportti
85 päivää sitten
1,55 DKK/osake
Viimeisin osinko
0,00%Tuotto/v

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 Q2 -tulosraportti
20.8.
Menneet tapahtumat
2026 Q1 -tulosraportti
7.5.
2025 Q4 -tulosraportti
5.2.
2025 Q3 -tulosraportti
6.11.2025
2025 Q2 -tulosraportti
21.8.2025
2025 Q1 -tulosraportti
1.5.2025

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 2 t sitten
    ·
    Read here what the investment economist, Per Hansen at Nordnet, writes about GN https://www.euroinvestor.dk/nyheder/oekonom-om-dansk-selskab-det-er-nu-eller-aldrig
    2 t sitten
    ·
    just go for it Per managed to buy the last ones so I reached 100,000 pcs.. could not wait for price 89
  • 2 t sitten · Muokattu
    ·
    All price triggers are charged up, the only thing missing now is their financial report showing that growth in enterprise is back and maybe even with a small upward revision, now that one can expect sales for the next 2 quarters to be with a competitor hopping on one leg😊 One could imagine a small short squeeze could happen, should GN drop an upward revision before the financial report or at the financial report if sales of Jabra 75 and 85, which have only been fully on the market this quarter, are good👌 I am at least currently a happy GN investor 😃
  • 5 t sitten
    ·
    5 short reports yesterday, 10.28 now
  • 6 t sitten
    ·
    Two financial reports in two days and both, in my opinion, provide interesting perspectives on GN's long-term investment case. 1. Logitech Logitech delivered a strong quarter with 7% revenue growth, higher earnings than expected, and continued solid demand for enterprise collaboration, video solutions, and gaming. This tells me that the market for premium peripherals and hybrid work continues to be healthy. 2. Amplifon The day after, Amplifon released a strong financial report: - 4.7% organic growth - THE highest in two years. - EBITDA margin increased to 25.8%. - Adjusted net profit increased 17%. - Free cash flow grew significantly. Management also maintained that the integration of GN Hearing is on track. The interesting thing is not just the individual reports, but the signals. Logitech shows that the market for enterprise hardware and gaming continues to be attractive. Amplifon shows that the hearing aid market is once again delivering growth and improved margins better than expected. For me, this indicates that GN's end markets continue to be very healthy. Yes, GN's own Q1 was operationally disappointing. But when two of the largest international players in areas that GN either competes in or has been exposed to, simultaneously deliver strong results, the focus shifts more from "weak market" to execution. This is precisely where the new GN case becomes interesting. After the sale of Hearing, GN is left with: - A significantly stronger balance sheet. - Focus on Jabra and SteelSeries. - An ownership stake of approximately 16% in Amplifon, which can develop positively if Amplifon continues its strong operational development. My investment case is therefore not about the next three months. It is about where GN stands in 2-5 years. If management succeeds in improving margins, regaining growth in Enterprise, and utilizing the financial flexibility after the Hearing transaction, I still believe that the market may underestimate the long-term potential. Therefore, I will follow the upcoming quarters very closely. *These are solely my own reflections and not a recommendation to buy or sell shares.*
    4 t sitten
    ·
    The Amplifon share is now trading at 12.08 Euro, which means that GN has now achieved an unrealized gain of 653 mill. DKK on its 56 mill. shares in Amplifon since the announcement of the divestment of Hearing.
  • 6 t sitten
    ·
    GNs stake in Amplifon rises almost 500 million today. 😮
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2026 Q1 -tulosraportti
85 päivää sitten
1,55 DKK/osake
Viimeisin osinko
0,00%Tuotto/v

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 2 t sitten
    ·
    Read here what the investment economist, Per Hansen at Nordnet, writes about GN https://www.euroinvestor.dk/nyheder/oekonom-om-dansk-selskab-det-er-nu-eller-aldrig
    2 t sitten
    ·
    just go for it Per managed to buy the last ones so I reached 100,000 pcs.. could not wait for price 89
  • 2 t sitten · Muokattu
    ·
    All price triggers are charged up, the only thing missing now is their financial report showing that growth in enterprise is back and maybe even with a small upward revision, now that one can expect sales for the next 2 quarters to be with a competitor hopping on one leg😊 One could imagine a small short squeeze could happen, should GN drop an upward revision before the financial report or at the financial report if sales of Jabra 75 and 85, which have only been fully on the market this quarter, are good👌 I am at least currently a happy GN investor 😃
  • 5 t sitten
    ·
    5 short reports yesterday, 10.28 now
  • 6 t sitten
    ·
    Two financial reports in two days and both, in my opinion, provide interesting perspectives on GN's long-term investment case. 1. Logitech Logitech delivered a strong quarter with 7% revenue growth, higher earnings than expected, and continued solid demand for enterprise collaboration, video solutions, and gaming. This tells me that the market for premium peripherals and hybrid work continues to be healthy. 2. Amplifon The day after, Amplifon released a strong financial report: - 4.7% organic growth - THE highest in two years. - EBITDA margin increased to 25.8%. - Adjusted net profit increased 17%. - Free cash flow grew significantly. Management also maintained that the integration of GN Hearing is on track. The interesting thing is not just the individual reports, but the signals. Logitech shows that the market for enterprise hardware and gaming continues to be attractive. Amplifon shows that the hearing aid market is once again delivering growth and improved margins better than expected. For me, this indicates that GN's end markets continue to be very healthy. Yes, GN's own Q1 was operationally disappointing. But when two of the largest international players in areas that GN either competes in or has been exposed to, simultaneously deliver strong results, the focus shifts more from "weak market" to execution. This is precisely where the new GN case becomes interesting. After the sale of Hearing, GN is left with: - A significantly stronger balance sheet. - Focus on Jabra and SteelSeries. - An ownership stake of approximately 16% in Amplifon, which can develop positively if Amplifon continues its strong operational development. My investment case is therefore not about the next three months. It is about where GN stands in 2-5 years. If management succeeds in improving margins, regaining growth in Enterprise, and utilizing the financial flexibility after the Hearing transaction, I still believe that the market may underestimate the long-term potential. Therefore, I will follow the upcoming quarters very closely. *These are solely my own reflections and not a recommendation to buy or sell shares.*
    4 t sitten
    ·
    The Amplifon share is now trading at 12.08 Euro, which means that GN has now achieved an unrealized gain of 653 mill. DKK on its 56 mill. shares in Amplifon since the announcement of the divestment of Hearing.
  • 6 t sitten
    ·
    GNs stake in Amplifon rises almost 500 million today. 😮
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 Q2 -tulosraportti
20.8.
Menneet tapahtumat
2026 Q1 -tulosraportti
7.5.
2025 Q4 -tulosraportti
5.2.
2025 Q3 -tulosraportti
6.11.2025
2025 Q2 -tulosraportti
21.8.2025
2025 Q1 -tulosraportti
1.5.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

2026 Q1 -tulosraportti
85 päivää sitten

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 Q2 -tulosraportti
20.8.
Menneet tapahtumat
2026 Q1 -tulosraportti
7.5.
2025 Q4 -tulosraportti
5.2.
2025 Q3 -tulosraportti
6.11.2025
2025 Q2 -tulosraportti
21.8.2025
2025 Q1 -tulosraportti
1.5.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

1,55 DKK/osake
Viimeisin osinko
0,00%Tuotto/v

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 2 t sitten
    ·
    Read here what the investment economist, Per Hansen at Nordnet, writes about GN https://www.euroinvestor.dk/nyheder/oekonom-om-dansk-selskab-det-er-nu-eller-aldrig
    2 t sitten
    ·
    just go for it Per managed to buy the last ones so I reached 100,000 pcs.. could not wait for price 89
  • 2 t sitten · Muokattu
    ·
    All price triggers are charged up, the only thing missing now is their financial report showing that growth in enterprise is back and maybe even with a small upward revision, now that one can expect sales for the next 2 quarters to be with a competitor hopping on one leg😊 One could imagine a small short squeeze could happen, should GN drop an upward revision before the financial report or at the financial report if sales of Jabra 75 and 85, which have only been fully on the market this quarter, are good👌 I am at least currently a happy GN investor 😃
  • 5 t sitten
    ·
    5 short reports yesterday, 10.28 now
  • 6 t sitten
    ·
    Two financial reports in two days and both, in my opinion, provide interesting perspectives on GN's long-term investment case. 1. Logitech Logitech delivered a strong quarter with 7% revenue growth, higher earnings than expected, and continued solid demand for enterprise collaboration, video solutions, and gaming. This tells me that the market for premium peripherals and hybrid work continues to be healthy. 2. Amplifon The day after, Amplifon released a strong financial report: - 4.7% organic growth - THE highest in two years. - EBITDA margin increased to 25.8%. - Adjusted net profit increased 17%. - Free cash flow grew significantly. Management also maintained that the integration of GN Hearing is on track. The interesting thing is not just the individual reports, but the signals. Logitech shows that the market for enterprise hardware and gaming continues to be attractive. Amplifon shows that the hearing aid market is once again delivering growth and improved margins better than expected. For me, this indicates that GN's end markets continue to be very healthy. Yes, GN's own Q1 was operationally disappointing. But when two of the largest international players in areas that GN either competes in or has been exposed to, simultaneously deliver strong results, the focus shifts more from "weak market" to execution. This is precisely where the new GN case becomes interesting. After the sale of Hearing, GN is left with: - A significantly stronger balance sheet. - Focus on Jabra and SteelSeries. - An ownership stake of approximately 16% in Amplifon, which can develop positively if Amplifon continues its strong operational development. My investment case is therefore not about the next three months. It is about where GN stands in 2-5 years. If management succeeds in improving margins, regaining growth in Enterprise, and utilizing the financial flexibility after the Hearing transaction, I still believe that the market may underestimate the long-term potential. Therefore, I will follow the upcoming quarters very closely. *These are solely my own reflections and not a recommendation to buy or sell shares.*
    4 t sitten
    ·
    The Amplifon share is now trading at 12.08 Euro, which means that GN has now achieved an unrealized gain of 653 mill. DKK on its 56 mill. shares in Amplifon since the announcement of the divestment of Hearing.
  • 6 t sitten
    ·
    GNs stake in Amplifon rises almost 500 million today. 😮
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt